http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20063471-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32305ca3a8c0b7e8cff4bd2dcd2baf65
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C13-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6f92ba3dfc1c2a34a762ba54ab9ad1e
publicationDate 2006-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20063471-L
titleOfInvention Preventive measures against liver cancer carcinogenesis containing quinone-based compound as active ingredient
abstract The present invention provides a safe and effective drug to prevent liver cancer carcinogenesis developed, first and foremost, from hepatitis C virus cirrhosis. The present invention provides a preventive agent for liver cancer carcinogenesis which contains menatetrenone as an active ingredient and which effectively prevents liver cancer carcinogenesis by administering such a preventive agent.
priorityDate 2004-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282367

Total number of triples: 22.